Form 8-K - Current report:
SEC Accession No. 0000950137-04-004198
Filing Date
2004-05-17
Accepted
2004-05-17 16:47:41
Documents
2
Period of Report
2004-05-17
Items
Item 12: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT c85638e8vk.txt 8-K 3256
2 PRESS RELEASE c85638exv99w1.txt EX-99.1 4004
  Complete submission text file 0000950137-04-004198.txt   8980
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 04813114
SIC: 2836 Biological Products, (No Diagnostic Substances)